Principal Investigators


LEHMANN Sylvain

Institution


CHU Montpellier

Contact information of lead PI


Country


France

Title of project or programme


Utilisation de la protéomique quantitative ciblée et du marquage aux isotopes stables pour le diagnostic et l’étude des affections neurologiques et en particulier de la maladie d’Alzheimer. Use of targeted quantitative proteomics and stable isotope labeling for the diagnosis and study of neurological disorders and in particular of Alzheimer's disease.

Source of funding information


DGOS

Total sum awarded (Euro)


€ 966,000

Start date of award


xx/xx/2010

Total duration of award in years


6.0

The project/programme is most relevant to:


Alzheimer's disease & other dementias

Keywords


Research Abstract


Lay Summary


Further information available at:

Export as PDF